Carboplatin/Piroxicam vs. Mitoxantrone/Piroxicam

Study Details:

Species: Canines

Tumor: Dogs with Anal sac Adenocarcinoma/gross disease

For more information: Click Here or CONTACT DR. MICHELE STEFFEY (530-752-1393) FOR INCLUSION IN THE STUDY.

Purpose of the Study Comparing the two different agents, Carboplatin/Piroxicam vs. Mitoxantrone/Piroxicam in patients with anal sac adenocarcinomas or gross disease.